Home |
Free Dividend Report |
Stock Splits Calendar |
CFRXW Historical Stock Prices |
Preferred Stock Newsletter |
Top Option Ideas |
Stock Message Boards |
CFRXW (CFRXW) has the following price history information. Looking back at CFRXW historical stock prices for the last five trading days, on January 20, 2017, CFRXW opened at $0.03, traded as high as $0.04 and as low as $0.03, and closed at $0.04. Trading volume was a total of 92.50K shares. On January 23, 2017, CFRXW opened at $0.03, traded as high as $0.04 and as low as $0.03, and closed at $0.03. Trading volume was a total of 46.00K shares. On January 24, 2017, CFRXW opened at $0.03, traded as high as $0.04 and as low as $0.03, and closed at $0.04. Trading volume was a total of 79.00K shares. On January 25, 2017, CFRXW opened at $0.03, traded as high as $0.03 and as low as $0.02, and closed at $0.03. Trading volume was a total of 110.30K shares. On January 26, 2017, CFRXW opened at $0.03, traded as high as $0.03 and as low as $0.01, and closed at $0.02. Trading volume was a total of 504.30K shares.
CFRXW Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into CFRXW shares, starting with a $10,000 purchase of CFRXW, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 11/14/2014 | |
End date: | 01/26/2017 | |
Start price/share: | $0.53 | |
End price/share: | $0.02 | |
Dividends collected/share: | $0.00 | |
Total return: | -95.82% | |
Average Annual Total Return: | -76.33% | |
Starting investment: | $10,000.00 | |
Ending investment: | $418.33 | |
Years: | 2.20 |
CFRXW Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
01/20/2017 | $0.03 | $0.04 | $0.03 | $0.04 | 92.50K |
01/23/2017 | $0.03 | $0.04 | $0.03 | $0.03 | 46.00K |
01/24/2017 | $0.03 | $0.04 | $0.03 | $0.04 | 79.00K |
01/25/2017 | $0.03 | $0.03 | $0.02 | $0.03 | 110.30K |
01/26/2017 | $0.03 | $0.03 | $0.01 | $0.02 | 504.30K |
About CFRXW |
ContraFect is a biotechnology company focused on discovering and developing therapeutic protein and antibody products to treat infectious diseases including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Co.'s lysin product candidate, CF-301, is for the treatment of Staph aureus bacteremia, including endocarditis, caused by methicillin-resistant or methicillin-susceptible. Co.'s second product candidate, CF-404, is a combination of three human monoclonal antibodies for the treatment of human influenza, including seasonal and pandemic varieties. Co. is also developing earlier stage programs that utilize the lysin and monoclonal antibody platforms. |
CFRXW Historical Closing Prices | |
Date | Close |
01/20/2017 | $0.04 |
01/23/2017 | $0.03 |
01/24/2017 | $0.04 |
01/25/2017 | $0.03 |
01/26/2017 | $0.02 |
Healthcare Historical Prices |
CFRXW is categorized under the Healthcare sector; below are some other companies in the same sector:
CFRXZ Historical Stock Prices
Free CFRXW Email Alerts:
|
CFRXW Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.